Metso Oyj
8.9100
23-12月-24 09:40:38
15 分の遅延
株式
-0.0520
-0.58%
本日の幅
8.8200 - 8.9620
ISIN
FI0009014575
ソース
NASD.OMX FI
-
Loop Capital Issues Positive Forecast for Klaviyo (NYSE:KVYO) Stock Price
23 12 2024 08:46:12 提供 Buzz FX
-
Citigroup Reaffirms Buy Rating for Cosan (NYSE:CSAN)
23 12 2024 08:46:12 提供 Buzz FX
-
Canaccord Genuity Group Reiterates Buy Rating for Vertical Aerospace (NYSE:EVTL)
23 12 2024 08:46:12 提供 Buzz FX
-
Datadog (NASDAQ:DDOG) Given New $200.00 Price Target at Loop Capital
23 12 2024 08:41:13 提供 Buzz FX
-
Assam Tea industry facing crisis amid rising costs and declining exports, say ATPA
23 12 2024 08:40:22 提供 Buzz FX
-
Gold News: Fed’s Hawkish Stance Pressures Prices as Holiday Trading Stalls
23 12 2024 08:36:18 提供 Buzz FX
-
Viewpoint: China SiMn prices face pressure in 2025
23 12 2024 08:26:25 提供 Buzz FX
-
Sources: Fed's Barr Seeks Legal Advice Amid Trump Removal Speculation | Newsmax.com
23 12 2024 08:26:25 提供 Buzz FX
-
Rockwell Medical (NASDAQ:RMTI) Earns "Buy" Rating from HC Wainwright
23 12 2024 08:26:12 提供 Buzz FX
-
23 12 2024 08:26:12 提供 Buzz FX
-
Lexicon Pharmaceuticals' (LXRX) Hold Rating Reaffirmed at Needham & Company LLC
23 12 2024 08:26:12 提供 Buzz FX
-
HC Wainwright Increases SoundHound AI (NASDAQ:SOUN) Price Target to $26.00
23 12 2024 08:26:12 提供 Buzz FX
-
Telsey Advisory Group Reiterates Outperform Rating for Kroger (NYSE:KR)
23 12 2024 08:26:12 提供 Buzz FX
-
HC Wainwright Reiterates "Buy" Rating for BrainsWay (NASDAQ:BWAY)
23 12 2024 08:26:12 提供 Buzz FX
-
HC Wainwright Reaffirms "Buy" Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)
23 12 2024 08:26:12 提供 Buzz FX
-
Rhythm Pharmaceuticals' (RYTM) Buy Rating Reaffirmed at HC Wainwright
23 12 2024 08:26:12 提供 Buzz FX
-
Mexico Prices Slow Less Than Expected, Backing Rate Cut Pace
23 12 2024 08:21:12 提供 Buzz FX
-
Piper Sandler Issues Positive Forecast for Enfusion (NYSE:ENFN) Stock Price
23 12 2024 08:16:12 提供 Buzz FX
-
Encore Capital Group (NASDAQ:ECPG) Given New $66.00 Price Target at Northland Securities
23 12 2024 08:16:12 提供 Buzz FX
-
Keros Therapeutics (NASDAQ:KROS) Price Target Cut to $43.00 by Analysts at Truist Financial
23 12 2024 08:16:12 提供 Buzz FX